Critical evaluation of urinary markers for bladder cancer detection and monitoring.

Authors:
  • SSShahrokh F Shariat
    Shahrokh F Shariat
  • JKJose A Karam
    Jose A Karam
  • YLYair Lotan
    Yair Lotan
  • PKPierre I Karakiewizc
    Pierre I Karakiewizc

Abstract
Bladder cancer is currently diagnosed using cystoscopy and cytology in patients with suspicious signs and symptoms. These tests are also used to monitor patients with a history of bladder cancer. The recurrence rate for bladder cancer is high, thus necessitating long-term follow-up. Urine cytology has high specificity but low sensitivity for low-grade bladder tumors. Recently, multiple noninvasive urine-based bladder cancer tests have been developed. Although several markers have been approved by the US Food and Drug Administration for bladder cancer surveillance, only a few are approved for detection of bladder cancer in high-risk patients.

This publication has 98 references indexed in Scilit: